UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

The New England journal of medicine, 2014-07, Vol.371 (2), p.130-139

2014

Volltextzugriff (PDF)

An RKHS Formulation of the Inverse Regression Dimension-Reduction Problem

The Annals of statistics, 2009-04, Vol.37 (2), p.726-755

2009

Volltextzugriff (PDF)

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee

Pain (Amsterdam), 2014-07, Vol.155 (7), p.1245-1252

2014

Volltextzugriff (PDF)

Anisotropy in creep-aging behavior of Al–Li alloy under different stress levels: experimental and constitutive modeling

Journal of materials research and technology, 2022-09, Vol.20, p.3456-3470

2022

Volltextzugriff (PDF)

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2310633-2310633

2024

Volltextzugriff (PDF)

Wear resistant aluminum alloy - B4C composites fabricated by rheo-casting and rolling process

Materials research express, 2020-05, Vol.7 (5), p.056525

2020

Volltextzugriff (PDF)

First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB158-AB158

2013

Volltextzugriff (PDF)

Safety and Efficacy Of Dupilumab Versus Placebo For Moderate-To-Severe Atopic Dermatitis In Patients Using Topical Corticosteroids (TCS): Greater Efficacy Observed With Concomitant Therapy Compared To TCS Alone

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB192-AB192

2014

Volltextzugriff (PDF)

Visual and quantitative evaluation of crack bonding rate of self-healing mortars based on volumetric strain analysis

Journal of cleaner production, 2024-04, Vol.450, p.141928, Article 141928

2024

Volltextzugriff (PDF)

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB404-AB404

2014

Volltextzugriff (PDF)

Chloride-ion-triggered microcapsule for self-suppression of capillary suction in cement paste

Cement & concrete composites, 2023-08, Vol.141, p.105144, Article 105144

2023

Volltextzugriff (PDF)

A tuned triboelectric nanogenerator using a magnetic liquid for low-frequency vibration energy harvesting

Nanoscale, 2024-01, Vol.16 (4), p.1915-1923

2024

Volltextzugriff (PDF)

Interfacial mechanical bond characterization between cement pastes and porous aggregates through a coupled XCT and DVC technique

Cement & concrete composites, 2023-09, Vol.142, p.105158, Article 105158

2023

Volltextzugriff (PDF)

396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

Asymmetry and deformation mechanism in stress relaxation of 7B50 alloy

Journal of alloys and compounds, 2024-11, Vol.1005, p.176056, Article 176056

2024

Volltextzugriff (PDF)

35163 Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator’s Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB202-AB202

2022

Volltextzugriff (PDF)

Influence of component damage on the mechanical performance of bracket set joints in ancient timber structures

European journal of environmental and civil engineering, 2022-06, Vol.26 (8), p.3258-3275

2022

Volltextzugriff (PDF)

44103 Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB84-AB84

2023

Volltextzugriff (PDF)

Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

Blood, 2021-11, Vol.138 (Supplement 1), p.1497-1497

2021

Volltextzugriff (PDF)

The discussion of the relationship between cardiopulmonary bypass and postoperative thyroid function changes in pediatric congenital heart disease, and the analysis of oral thyroid hormone therapy and cardiac prognosis

Perfusion, 2024-11, p.2676591241298200

2024

Volltextzugriff (PDF)

Real-world (RW) characteristics, treatment patterns, and outcomes of patients with cholangiocarcinoma (CCA) treated with pemigatinib

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.444-444

2024

Volltextzugriff (PDF)

Real-world use of pemigatinib (pemi) for cholangiocarcinoma (CCA) among racial and ethnic minorities in the United States

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.461-461

2024

Volltextzugriff (PDF)

Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US

The oncologist (Dayton, Ohio), 2024-08

2024

Volltextzugriff (PDF)

Investigating mechanism for mortar-porous aggregate interfacial bond improvement based on coupled XCT-DVC analysis

Journal of Building Engineering, 2023-12, Vol.80, p.107952, Article 107952

2023

Volltextzugriff (PDF)

34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB180-AB180

2022

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(152)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Technology
(41)
Life Sciences & Biomedicine
(39)
Physical Sciences
(28)
Materials Science
(20)
Engineering
(19)
Humans
(19)
Materials Science, Multidisciplinary
(11)
Male
(10)
Chemistry
(9)
Science & Technology - Other Topics
(9)
Animals
(8)
Engineering, Electrical & Electronic
(8)
Female
(8)
Dermatology
(7)
Mathematics
(7)
Biochemistry & Molecular Biology
(6)
Geology
(6)
Geosciences, Multidisciplinary
(6)
Quality Of Life
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

An RKHS Formulation of the Inverse Regression Dimension-Reduction Problem

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee

Anisotropy in creep-aging behavior of Al–Li alloy under different stress levels: experimental and constitutive modeling

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

Wear resistant aluminum alloy - B4C composites fabricated by rheo-casting and rolling process

First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers

Safety and Efficacy Of Dupilumab Versus Placebo For Moderate-To-Severe Atopic Dermatitis In Patients Using Topical Corticosteroids (TCS): Greater Efficacy Observed With Concomitant Therapy Compared To TCS Alone

Visual and quantitative evaluation of crack bonding rate of self-healing mortars based on volumetric strain analysis

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Chloride-ion-triggered microcapsule for self-suppression of capillary suction in cement paste

A tuned triboelectric nanogenerator using a magnetic liquid for low-frequency vibration energy harvesting

Interfacial mechanical bond characterization between cement pastes and porous aggregates through a coupled XCT and DVC technique

396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)

Asymmetry and deformation mechanism in stress relaxation of 7B50 alloy

35163 Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator’s Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies

Influence of component damage on the mechanical performance of bracket set joints in ancient timber structures

44103 Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies

Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

The discussion of the relationship between cardiopulmonary bypass and postoperative thyroid function changes in pediatric congenital heart disease, and the analysis of oral thyroid hormone therapy and cardiac prognosis

Real-world (RW) characteristics, treatment patterns, and outcomes of patients with cholangiocarcinoma (CCA) treated with pemigatinib

Real-world use of pemigatinib (pemi) for cholangiocarcinoma (CCA) among racial and ethnic minorities in the United States

Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US

Investigating mechanism for mortar-porous aggregate interfacial bond improvement based on coupled XCT-DVC analysis

34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies

Aktive Filter

Suchergebnisse filtern